Polaryx Logo PARAMUS, NJ, UNITED STATES, February 26, 2025 /EINPresswire / -- Polaryx Therapeutics , a late-stage clinical biotech company dev ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.

Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be ...

Find new ideas and classic advice on strategy, innovation and leadership, for global leaders from the world's best business and management experts.

The FDA granted approval of Merilog to Sanofi (SNY)-Aventis U.S. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top ...

Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by the E.coli bacteria due to a lack of sufficient efficacy, the companies ...

Discover the Top 20 best Fashion Logos that define style in the industry! From iconic to innovative, explore how these logos captivate audiences! In fashion, logos are more than just symbols; they are ...

Biogen forecast 2025 profit below Wall Street expectations on Wednesday, hurt by a strong dollar and fierce competition for its drugs to treat multiple sclerosis. Investors sold Biogen shares in 2024 ...

OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. Emma Roth is a news writer ...

Sales of anti-inflammatory drug Dupixent rose 15% to $3.7 billion. The French partner, Sanofi (SASY.PA), opens new tab, records Dupixent's sales and the profits are split equally between the ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Starting a new job search? Take the first step with these ...

L’Oreal OR0.83%increase; green up pointing triangle will sell part of its stake in Sanofi SAN-0.46%decrease; red down pointing triangle back to the French pharmaceutical company for 3 billion ...